Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
An announcement from Modern Chinese Medicine Group Co. Ltd. ( (HK:1643) ) is now available.
Modern Chinese Medicine Group Co., Ltd. has obtained a waiver from the Hong Kong Stock Exchange regarding the timing requirements for sending a shareholder circular linked to a major share acquisition. The delay stems from the need for more time to finalize key financial information, including the consolidated audited report of the target group for the three years ended 31 December 2025.
With the waiver granted on 11 February 2026, the company now has until 30 April 2026 to dispatch the circular, extending the original deadline of 9 February 2026. The extension indicates regulatory flexibility but also underscores the importance of complete and audited financial disclosures for investors, while the exchange retains the right to withdraw or change the waiver if circumstances shift.
The most recent analyst rating on (HK:1643) stock is a Hold with a HK$0.91 price target. To see the full list of analyst forecasts on Modern Chinese Medicine Group Co. Ltd. stock, see the HK:1643 Stock Forecast page.
More about Modern Chinese Medicine Group Co. Ltd.
Modern Chinese Medicine Group Co., Ltd. is a Hong Kong-listed company incorporated in the Cayman Islands and engaged in the Chinese medicine sector. The group operates under stock code 1643 and is governed by a board comprising executive and independent non-executive directors, reflecting a typical corporate governance structure for a listed healthcare company in the region.
Average Trading Volume: 1,140,466
Technical Sentiment Signal: Buy
Current Market Cap: HK$640.8M
For an in-depth examination of 1643 stock, go to TipRanks’ Overview page.